Results 41 to 50 of about 9,370 (298)

The work of compounding pharmacies and the possible risks of violating the exclusive rights to original medicines

Фармация и фармакология (Пятигорск)
The revival of production pharmacies in Russia began in 2022. To effectively use the capabilities of compounding pharmacies, it is necessary to take into account the importance of eliminating the risk of infringement of intellectual property rights.The ...
A. V. Alekhin, T. N. Erivantseva, V. O. Kalyatin, R. A. Ivanov, N. A. Alekhina   +4 more
doaj   +1 more source

Investigating the knowledge, perception, and practice of healthcare practitioners toward rational use of compounded medications and its contribution to antimicrobial resistance: a cross-sectional study

BMC Health Services Research, 2022
Background Pharmaceutical compounding ensures access of individuals with specific requirements to individualized therapy. However, there is an inconsistency of compounded medication quality.
Desta Assefa, Getahun Paulos, Dereje Kebebe, Sintayehu Alemu, Wondu Reta, Temesgen Mulugeta, Fanta Gashe   +6 more
doaj   +1 more source

Evaluation of Robotic Systems on Cytotoxic Drug Preparation: A Systematic Review and Meta-Analysis

Medicina, 2023
Background and Objectives: With the increased prevalence of patients with cancer, the demand for preparing cytotoxic drugs was increased by health-system pharmacists.
Sangyoon Shin, Jamin Koo, Suk Won Kim, Seungyeon Kim, So Yeon Hong, Euni Lee   +5 more
doaj   +1 more source

Pharmacy Compounding Regulation in the German Pharmaceutical Market. Part 1. Basic Regulatory Provisions (Review)

Регуляторные исследования и экспертиза лекарственных средств
SCIENTIFIC RELEVANCE. There is a need to move towards an appropriate system of quality assurance in pharmacy compounding. At the same time, the development of a Russian regulatory system for pharmacy compounding requires a broad understanding of ...
S. E. Erdni-Garyaev, D. D. Mamedov, D. S. Yurochkin, D. D. Zelikova, Z. M. Golant, V. S. Fisenko, I. A. Narkevich   +6 more
doaj   +1 more source

Basiscreme DAC: Characteristics and possibility of use for compounding drugs in pharmacy [PDF]

Arhiv za farmaciju, 2015
Despite prescribing of industrially produced dermatological preparations, successful local treatment of certain diseases is still dependent on the knowledge and skills of pharmacists when compounding magistral and galenic drugs.
Martinović Martina, Stanković Nina, Vuleta Gordana   +2 more
doaj   +1 more source

Medicines manufactured in pharmacies: features of validation of analytical methods and tests (Prior to the introduction of the monograph section of the SPU)

Фармацевтичний журнал, 2021
In most foreign countries, compounding medicines preparation are an important element of the pharmaceutical sector, the formulation of which is being distributed and developed taking into account the needs of today. Legal regulation of the circulation of
O. A. Yevtifieieva, V. A. Georgiyants
doaj   +1 more source

Pharmacy Compounding Regulation in the German Pharmaceutical Market. Part 2. Organisational Features (Review)

Регуляторные исследования и экспертиза лекарственных средств
INTRODUCTION. The Russian Federation has decided to restore the system of compounding pharmacies as an element of the critical national healthcare infrastructure and pharmaceutical supply chain.
S. E. Erdni-Garyaev, D. D. Mamedov, D. S. Yurochkin, D. D. Zelikova, Z. M. Golant, V. S. Fisenko, I. A. Narkevich   +6 more
doaj   +1 more source

Changing paradigms of anti-VEGF in the Indian scenario

Indian Journal of Ophthalmology, 2014
Anti-vascular endothelial growth factors (VEGF) agents have revolutionized the treatment of retinal diseases. Use of anti-VEGF agents in the Indian Scenario present some unique challenges considering the absence of compounding pharmacies, poor penetrance
P Mahesh Shanmugam
doaj   +1 more source

Real‐World Pediatric Blinatumomab Administration: Access to Outpatient Care Delivery and Impact of a Hospital‐Dispensed Model

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Blinatumomab has been shown to be highly effective for patients with pediatric B‐ALL and has recently become standard of care therapy. Due to its past use in the clinical trial setting, there is limited information available about real‐world administration.
Katelyn Oranges, Kelly A. Duffy, Sara McDonough, Evelyn Kurpiewski, R. Jennifer Randall, Allison Barz Leahy, Haley M. Newman, Joyce P. Lee, Stephen P. Hunger, Anne F. Reilly, David T. Teachey, Susan R. Rheingold, Daniel J. Zheng   +12 more
wiley   +1 more source

Preferences of Pediatric Patients and Their Caregivers for Chemotherapy‐Induced Nausea and Vomiting Control Endpoints: A Mixed Methods Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Although not always achieved, complete chemotherapy‐induced nausea and vomiting (CINV) control is the conventional goal of CINV prophylaxis. In this two‐center, mixed‐methods study, we sought to understand the preferences of adolescent patients and family caregivers for CINV control endpoints.
Haley Newman, Tadi Hondonga, Alison Berry, Caitlin Elgarten, Jason Freedman, Katelyn Oranges, Sara McDonough, Caroline Diorio, L. Lee Dupuis   +8 more
wiley   +1 more source